Any current/future new fundraising through debt or equity?

Yasho Industries is currently focusing on reducing its debt-to-EBITDA ratio to a comfort zone of around 2.5x. The company does not plan to increase debt significantly until this ratio is achieved, although the absolute debt number might rise. The INR125 crores capex planned for FY27 will be funded through internal accruals, not through new strategic debt or equity. There is no mention of any immediate equity fundraising. The company aims to manage working capital efficiently and maintain financial discipline without aggressive new fundraising in the short term.

Any current/future capex/capital investment/strategic investment?

FY '26 capex: INR 75 crores, including INR 42 crores at Pakhajan and about INR 7-8 crores at Vapi; INR 25 crores spent on R&D. FY '27 planned capex: INR 125 crores, purely at Pakhajan; no capex contribution from the MNC project (separate). Additional special project at Pakhajan with INR 90 crores capex ongoing. Future capacity expansion at Pakhajan involves building additional production buildings (4 more possible). Long-term contract signed in FY '26 with an advance of INR 51.4 crores; revenue expected from this starting FY '28. No CDMO-style capex; focus on large-volume production

Future growth expectations in sales/revenue/volumes?

FY26 volume growth was 33% year-on-year. FY27 volume growth expected to be between 40% to 50%, driven by 15% increase in capacity utilization. Capacity utilization targeted to ramp up to 75% by FY27. FY28 revenue guidance is approximately INR 1,500 crores, including: - Capacity expansion done in FY26. - Commercialization of a long-term contract/project contributing to growth. Volume growth primarily driven by the industrial segment; consumer segment may see slight dip. Prices stable overall, with some volatility in specific solvents; price increases of 10-15% expected starting FY27. Beyond

Future growth expectations in earnings/operating earnings/profits/EPS?

Volume growth expected between 35% to 45% in FY27, with capacity utilization increasing by about 15%. Targeting revenue of approximately INR1,500 crores by FY28, driven by capacity expansions and a long-term contract operational from FY28. EBITDA margins anticipated to improve by 2-3%, supported by higher utilization (70%-75% in FY27) and operational efficiencies, targeting around 20%+ EBITDA margin. Gross margins expected to be stable between 40%-42% in the medium term, due to improved asset utilization and cost rationalization. FY27 capex planned at INR125 crores, funded entirely via

Current/ Expected Orderbook/ Pending Orders?

The management did not explicitly mention a current or expected order book value during the call. However, there is reference to commitments from customers based on gained confidence due to supply reliability, supporting the guidance of 70%-75% capacity utilization. A strategic large project for an MNC is expected to start contributing commercially from early FY28, indicating some secured future orders. About 40% of revenue in Q4 FY26 came from contracts with fixed pricing (quarterly or 6-monthly), and 60% from spot or regular customers, implying a mix of confirmed and variable orders. There i

IN US

Sale is live|00:00:00left today

Yasho Industries LtdQ1 FY26Chemicals & Petrochemicals

Yasho Industries Ltd Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹2,868P/E: 113.4Market Cap: ₹2.0K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

Yes

Order

N/A

Capex

Yes

3 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→FY26 volume growth was 33% year-on-year.
→FY27 volume growth expected to be between 40% to 50%, driven by 15% increase in capacity utilization.
→Capacity utilization targeted to ramp up to 75% by FY27.
→FY28 revenue guidance is approximately INR 1,500 crores, including:
→ - Capacity expansion done in FY26.
→ - Commercialization of a long-term contract/project contributing to growth.
→Volume growth primarily driven by the industrial segment; consumer segment may see slight dip.
→Prices stable overall, with some volatility in specific solvents; price increases of 10-15% expected starting FY27.
→Beyond FY28, growth will be fueled by leveraging current assets at higher utilization (85-90%), introducing new molecules/products, and expanding into performance chemicals beyond traditional segments.

Margin guidance

Category 1

→Volume growth expected between 35% to 45% in FY27, with capacity utilization increasing by about 15%.
→Targeting revenue of approximately INR1,500 crores by FY28, driven by capacity expansions and a long-term contract operational from FY28.
→EBITDA margins anticipated to improve by 2-3%, supported by higher utilization (70%-75% in FY27) and operational efficiencies, targeting around 20%+ EBITDA margin.
→Gross margins expected to be stable between 40%-42% in the medium term, due to improved asset utilization and cost rationalization.
→FY27 capex planned at INR125 crores, funded entirely via internal accruals, expected to support new product launches and capacity expansions.
→Long-term 15-year contract provides revenue visibility from FY28 onwards, backed by INR51.4 crores advance received.
→Despite global challenges, operational and financial discipline aims to deliver consistent and profitable growth.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes

→Yasho Industries is currently focusing on reducing its debt-to-EBITDA ratio to a comfort zone of around 2.5x.
→The company does not plan to increase debt significantly until this ratio is achieved, although the absolute debt number might rise.
→The INR125 crores capex planned for FY27 will be funded through internal accruals, not through new strategic debt or equity.
→There is no mention of any immediate equity fundraising.
→The company aims to manage working capital efficiently and maintain financial discipline without aggressive new fundraising in the short term.

Order book

→The management did not explicitly mention a current or expected order book value during the call.
→However, there is reference to commitments from customers based on gained confidence due to supply reliability, supporting the guidance of 70%-75% capacity utilization.
→A strategic large project for an MNC is expected to start contributing commercially from early FY28, indicating some secured future orders.
→About 40% of revenue in Q4 FY26 came from contracts with fixed pricing (quarterly or 6-monthly), and 60% from spot or regular customers, implying a mix of confirmed and variable orders.
→There is no disclosed exact monetary value or backlog figure disclosed for pending orders.
→Management emphasized healthy demand visibility and customer penetration, but did not quantify order book size.

Capex plans

Yes

→FY '26 capex: INR 75 crores, including INR 42 crores at Pakhajan and about INR 7-8 crores at Vapi; INR 25 crores spent on R&D.
→FY '27 planned capex: INR 125 crores, purely at Pakhajan; no capex contribution from the MNC project (separate).
→Additional special project at Pakhajan with INR 90 crores capex ongoing.
→Future capacity expansion at Pakhajan involves building additional production buildings (4 more possible).
→Long-term contract signed in FY '26 with an advance of INR 51.4 crores; revenue expected from this starting FY '28.
→No CDMO-style capex; focus on large-volume production (minimum 500-1,000 metric tons).
→The company aims to reach 75%+ utilization by FY '28, supported by capacity expansions and leveraging strategic contracts.

How does Yasho Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Yasho Industries Ltd

Rev 2Mar 1

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Yasho Industries Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio